181 related articles for article (PubMed ID: 18952429)
21. Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.
Selcen D; Bromberg MB; Chin SS; Engel AG
Neurology; 2011 Nov; 77(22):1951-9. PubMed ID: 22094483
[TBL] [Abstract][Full Text] [Related]
22. Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.
Malfatti E; Olivé M; Taratuto AL; Richard P; Brochier G; Bitoun M; Gueneau L; Laforêt P; Stojkovic T; Maisonobe T; Monges S; Lubieniecki F; Vasquez G; Streichenberger N; Lacène E; Saccoliti M; Prudhon B; Alexianu M; Figarella-Branger D; Schessl J; Bonnemann C; Eymard B; Fardeau M; Bonne G; Romero NB
J Neuropathol Exp Neurol; 2013 Sep; 72(9):833-45. PubMed ID: 23965743
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of loss of Fhl1 expression in human gastric cancer.
Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
Ann Surg Oncol; 2008 Aug; 15(8):2293-300. PubMed ID: 18465173
[TBL] [Abstract][Full Text] [Related]
24. Novel FHL1 mutations in fatal and benign reducing body myopathy.
Shalaby S; Hayashi YK; Nonaka I; Noguchi S; Nishino I
Neurology; 2009 Jan; 72(4):375-6. PubMed ID: 19171836
[No Abstract] [Full Text] [Related]
25. [Childhood reducing body myopathy caused by FHL1 gene variation in a child].
Wei CJ; Wang ZX; Chang XZ; Lyu JL; Ge L; Fan YB; Zhang YH; Xiong H
Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):147-149. PubMed ID: 32102154
[TBL] [Abstract][Full Text] [Related]
26. The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle.
Morgan MJ; Madgwick AJ
Biochem Biophys Res Commun; 1999 Feb; 255(2):245-50. PubMed ID: 10049693
[TBL] [Abstract][Full Text] [Related]
27. Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion.
Willis TA; Wood CL; Hudson J; Polvikoski T; Barresi R; Lochmüller H; Bushby K; Straub V
Clin Genet; 2016 Aug; 90(2):166-70. PubMed ID: 27409453
[TBL] [Abstract][Full Text] [Related]
28. The LIM-domain protein FHL1 (SLIM 1) exhibits functional regulation in skeletal muscle.
Loughna PT; Mason P; Bayol S; Brownson C
Mol Cell Biol Res Commun; 2000 Mar; 3(3):136-40. PubMed ID: 10860860
[TBL] [Abstract][Full Text] [Related]
29. Myofibrillar myopathy caused by a novel FHL1 mutation presenting a mild myopathy with ankle contracture.
Park YE; Kim DS; Shin JH
Clin Neurol Neurosurg; 2019 May; 180():48-51. PubMed ID: 30928807
[TBL] [Abstract][Full Text] [Related]
30. Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death.
Xue Y; Schoser B; Rao AR; Quadrelli R; Vaglio A; Rupp V; Beichler C; Nelson SF; Schapacher-Tilp G; Windpassinger C; Wilcox WR
Circ Cardiovasc Genet; 2016 Apr; 9(2):130-5. PubMed ID: 26933038
[TBL] [Abstract][Full Text] [Related]
31. A case of adult-onset reducing body myopathy presenting a novel clinical feature, asymmetrical involvement of the sternocleidomastoid and trapezius muscles.
Fujii T; Hayashi S; Kawamura N; Higuchi MA; Tsugawa J; Ohyagi Y; Hayashi YK; Nishino I; Kira J
J Neurol Sci; 2014 Aug; 343(1-2):206-10. PubMed ID: 24928078
[TBL] [Abstract][Full Text] [Related]
32. A Dominant C150Y Mutation in FHL1 Induces Structural Alterations in LIM2 Domain Causing Protein Aggregation In Human and Drosophila Indirect Flight Muscles.
Santhoshkumar R; Preethish-Kumar V; Mangalaparthi KK; Unni S; Padmanabhan B; T S KP; Nongthomba U; Atchayaram N; Narayanappa G
J Mol Neurosci; 2021 Nov; 71(11):2324-2335. PubMed ID: 33515430
[TBL] [Abstract][Full Text] [Related]
33. Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
Yang Z; Browning CF; Hallaq H; Yermalitskaya L; Esker J; Hall MR; Link AJ; Ham AJ; McGrath MJ; Mitchell CA; Murray KT
Cardiovasc Res; 2008 Jun; 78(3):449-57. PubMed ID: 18281375
[TBL] [Abstract][Full Text] [Related]
34. A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations.
Keßler M; Kieltsch A; Kayvanpour E; Katus HA; Schoser B; Schessl J; Just S; Rottbauer W
Neuromuscul Disord; 2018 Jun; 28(6):521-531. PubMed ID: 29735270
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel FHL1 mutations associated with X-linked scapuloperoneal myopathy in unrelated Chinese patients.
Lin Y; Ban R; Qiao L; Chen J; Liu M; Liu J; Shi Q
J Hum Genet; 2023 Jul; 68(7):477-484. PubMed ID: 36864287
[TBL] [Abstract][Full Text] [Related]
36. Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice.
Domenighetti AA; Chu PH; Wu T; Sheikh F; Gokhin DS; Guo LT; Cui Z; Peter AK; Christodoulou DC; Parfenov MG; Gorham JM; Li DY; Banerjee I; Lai X; Witzmann FA; Seidman CE; Seidman JG; Gomes AV; Shelton GD; Lieber RL; Chen J
Hum Mol Genet; 2014 Jan; 23(1):209-25. PubMed ID: 23975679
[TBL] [Abstract][Full Text] [Related]
37. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1.
Quinzii CM; Vu TH; Min KC; Tanji K; Barral S; Grewal RP; Kattah A; Camaño P; Otaegui D; Kunimatsu T; Blake DM; Wilhelmsen KC; Rowland LP; Hays AP; Bonilla E; Hirano M
Am J Hum Genet; 2008 Jan; 82(1):208-13. PubMed ID: 18179901
[TBL] [Abstract][Full Text] [Related]
38. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy.
Feldkirchner S; Walter MC; Müller S; Kubny C; Krause S; Kress W; Hanisch FG; Schoser B; Schessl J
Neuromuscul Disord; 2013 May; 23(5):418-26. PubMed ID: 23489660
[TBL] [Abstract][Full Text] [Related]
39. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.
Giucă A; Mitu C; Popescu BO; Bastian AE; Capşa R; Mursă A; Rădoi V; Popescu BA; Jurcuţ R
BMC Med Genet; 2020 Sep; 21(1):188. PubMed ID: 32993534
[TBL] [Abstract][Full Text] [Related]
40. SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis.
Cottle DL; McGrath MJ; Wilding BR; Cowling BS; Kane JM; D'Arcy CE; Holdsworth M; Hatzinisiriou I; Prescott M; Brown S; Mitchell CA
J Biol Chem; 2009 Sep; 284(39):26964-77. PubMed ID: 19643733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
